Showing 24,141 - 24,160 results of 24,706 for search 'institution program', query time: 0.23s Refine Results
  1. 24141
  2. 24142
  3. 24143

    Synergistic Induction of Immunogenic Cell Death by Biomineralized Manganese and Bisphosphonates Enhances Anti-PD-L1 Therapy in Triple-Negative Breast Cancer by Zhang X, Liu N, Wei M, Yang C, Lin Y, Zeng Y, Li Y, Zhou L, Li T, Zheng Q, Yu H, Zhang J, Gu Y, Xia N, Li S

    Published 2025-04-01
    “…Xiuli Zhang,1,2,* Nan Liu,1,2,* Mingjing Wei,1,2 Chuanlai Yang,1,2 Yanhua Lin,1,2 Yarong Zeng,1,2 Yufang Li,1,2 Lizhi Zhou,1,2 Tingting Li,1,2 Qingbing Zheng,1,2 Hai Yu,1,2 Jun Zhang,1,2 Ying Gu,1,2 Ningshao Xia,1,2 Shaowei Li1,2 1State Key Laboratory of Vaccines for Infectious Diseases, XiangAn Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, People’s Republic of China; 2National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, The Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, Xiamen, People’s Republic of China*These authors contributed equally to this workCorrespondence: Shaowei Li, Email shaowei@xmu.edu.cn Ying Gu, Email guying@xmu.edu.cnBackground: Despite therapeutic benefits of anti-Programmed Death-Ligand 1 (PD-L1) therapy in triple-negative breast cancer (TNBC), low response rates and resistance limit its efficacy. …”
    Get full text
    Article
  4. 24144
  5. 24145
  6. 24146
  7. 24147
  8. 24148
  9. 24149
  10. 24150
  11. 24151
  12. 24152
  13. 24153
  14. 24154
  15. 24155
  16. 24156
  17. 24157
  18. 24158
  19. 24159
  20. 24160